Literature DB >> 29254888

FOCUS4: a new trial design for evaluation of targeted drugs in colorectal cancer?

Hans-Joachim Schmoll1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29254888     DOI： 10.1016/S2468-1253(17)30402-8

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


× No keyword cloud information.
  5 in total

1.  Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.

Authors:  Laura M Yee; Lisa M McShane; Boris Freidlin; Margaret M Mooney; Edward L Korn
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

2.  Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation.

Authors:  Myrto Lee; Hoan Ly; Clemens C Möller; Michael S Ringel
Journal:  Clin Pharmacol Ther       Date:  2019-04       Impact factor: 6.875

Review 3.  Tailored Systemic Therapy for Colorectal Cancer Liver Metastases.

Authors:  Carolin Czauderna; Kim Luley; Nikolas von Bubnoff; Jens U Marquardt
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

4.  Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?

Authors:  Peter C Elwood; Janet E Pickering; Gareth Morgan; Julieta Galante; Alison L Weightman; Delyth Morris; Marcus Longley; Malcolm Mason; Richard Adams; Sunil Dolwani; John Chia W K; Angel Lanas
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240

5.  Training and accreditation standards for pathologists undertaking clinical trial work.

Authors:  Gabrielle Rees; Manuel Salto-Tellez; Jessica L Lee; Karin Oien; Clare Verrill; Alex Freeman; Ilaria Mirabile; Nicholas P West
Journal:  J Pathol Clin Res       Date:  2019-02-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.